These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12117891)

  • 1. Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics.
    Baeres M; Herkel J; Czaja AJ; Wies I; Kanzler S; Cancado EL; Porta G; Nishioka M; Simon T; Daehnrich C; Schlumberger W; Galle PR; Lohse AW
    Gut; 2002 Aug; 51(2):259-64. PubMed ID: 12117891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis.
    Zachou K; Gampeta S; Gatselis NK; Oikonomou K; Goulis J; Manoussakis MN; Renaudineau Y; Bogdanos DP; Dalekos GN
    Liver Int; 2015 Feb; 35(2):660-72. PubMed ID: 25113420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis.
    Wies I; Brunner S; Henninger J; Herkel J; Kanzler S; Meyer zum Büschenfelde KH; Lohse AW
    Lancet; 2000 Apr; 355(9214):1510-5. PubMed ID: 10801173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-soluble liver antigen/liver-pancreas (SLA/LP) antibodies in pediatric patients with autoimmune hepatitis.
    Vitozzi S; Djilali-Saiah I; Lapierre P; Alvarez F
    Autoimmunity; 2002 Dec; 35(8):485-92. PubMed ID: 12765473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay.
    Miyakawa H; Kawashima Y; Kitazawa E; Kawaguchi N; Kato T; Kikuchi K; Imai E; Fujikawa H; Hashimoto E; Schlumberger W
    J Autoimmun; 2003 Aug; 21(1):77-82. PubMed ID: 12892738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of antibodies to soluble liver antigen/liver pancreas: a large French study.
    Eyraud V; Chazouilleres O; Ballot E; Corpechot C; Poupon R; Johanet C
    Liver Int; 2009 Jul; 29(6):857-64. PubMed ID: 19302185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permanent immunosuppression in SLA/LP-positive autoimmune hepatitis is required although overall response and survival are similar.
    Zachou K; Weiler-Normann C; Muratori L; Muratori P; Lohse AW; Dalekos GN
    Liver Int; 2020 Feb; 40(2):368-376. PubMed ID: 31626725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study.
    Efe C; Ozaslan E; Wahlin S; Purnak T; Muratori L; Quarneti C; Yüksel O; Muratori P
    Liver Int; 2013 Feb; 33(2):190-6. PubMed ID: 23295051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tRNP(ser)sec/SLA/LP autoantibodies. Comparative study using in-house ELISA with a recombinant 48.8 kDa protein, immunoblot, and analysis of immunoprecipitated RNAs.
    Torres-Collado AX; Czaja AJ; Gelpí C
    Liver Int; 2005 Apr; 25(2):410-9. PubMed ID: 15780067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis.
    Volkmann M; Martin L; Bäurle A; Heid H; Strassburg CP; Trautwein C; Fiehn W; Manns MP
    Hepatology; 2001 Mar; 33(3):591-6. PubMed ID: 11230739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease.
    Ma Y; Okamoto M; Thomas MG; Bogdanos DP; Lopes AR; Portmann B; Underhill J; Dürr R; Mieli-Vergani G; Vergani D
    Hepatology; 2002 Mar; 35(3):658-64. PubMed ID: 11870381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLA/LP/tRNP((Ser)Sec) antigen in autoimmune hepatitis: identification of the native protein in human hepatic cell extract.
    Volkmann M; Luithle D; Zentgraf H; Schnölzer M; Fiedler S; Heid H; Schulze-Bergkamen A; Strassburg CP; Gehrke SG; Manns MP
    J Autoimmun; 2010 Feb; 34(1):59-65. PubMed ID: 19683415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis.
    Czaja AJ; Donaldson PT; Lohse AW
    Am J Gastroenterol; 2002 Feb; 97(2):413-9. PubMed ID: 11866281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas.
    Herkel J; Heidrich B; Nieraad N; Wies I; Rother M; Lohse AW
    Hepatology; 2002 Feb; 35(2):403-8. PubMed ID: 11826415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The significance of anti-soluble liver antigen/liver-pancreas in diagnosing and typing autoimmune hepatitis].
    Zhao Y; Yan HP; Tan YF; Feng X; Liu Y; Cui D; Ma DM; Li WH; Zhang HP
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):283-6. PubMed ID: 17456317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)].
    Kanzler S; Bozkurt S; Herkel J; Galle PR; Dienes HP; Lohse AW
    Dtsch Med Wochenschr; 2001 Apr; 126(16):450-6. PubMed ID: 11360449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
    Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
    Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis.
    Zhang WC; Zhao FR; Chen J; Chen WX
    PLoS One; 2014; 9(3):e92267. PubMed ID: 24651126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis.
    Czaja AJ; Shums Z; Norman GL
    Autoimmunity; 2002 Dec; 35(8):475-83. PubMed ID: 12765472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis.
    Ballot E; Homberg JC; Johanet C
    J Hepatol; 2000 Aug; 33(2):208-15. PubMed ID: 10952238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.